Initial experience with percutaneous mitral valve repair in patients with cardiac amyloidosis

Background Percutaneous mitral valve repair (PMVR) is a therapeutic option for severe mitral regurgitation (MR) in patients with heart failure due to differential aetiologies. However, only little is known about the safety and efficacy of this procedure in patients with amyloid cardiomyopathy. Metho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of clinical investigation 2021-06, Vol.51 (6), p.e13473-n/a, Article 13473
Hauptverfasser:	Volz, Martin J., Pleger, Sven T., Weber, Andreas, Geis, Nicolas A., Hamed, Sonja, Mereles, Derliz, Hegenbart, Ute, Katus, Hugo A., Frey, Norbert, Raake, Philip W., Kreusser, Michael M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Amyloid amyloid cardiomyopathy Amyloidosis Amyloidosis - complications Amyloidosis - physiopathology Biomarkers cardiac amyloidosis Cardiac Catheterization - methods Cardiomyopathies - complications Cardiomyopathies - physiopathology Cardiomyopathy Congestive heart failure Female General & Internal Medicine Heart valves Humans Life Sciences & Biomedicine Male Medicine, General & Internal Medicine, Research & Experimental mitral regurgitation Mitral valve Mitral Valve Annuloplasty - methods Mitral Valve Insufficiency - complications Mitral Valve Insufficiency - physiopathology Mitral Valve Insufficiency - surgery percutaneous mitral valve repair Regurgitation Renal function Research & Experimental Medicine Retrospective Studies Risk assessment Safety Science & Technology Survival Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!